Subscribe To
Acme lithium commences test well at clayton valley lithium brine project as it completes dh-1a drill hole
ACME Lithium Inc. (CSE:ACME, OTCQB:ACLHF) told investors drilling of its Dissolved Mineral Resource Exploration (DMRE) test well TW-1 has commenced a...
April 24, 2023, 8:19 am
Eur/usd eyes additional gains above 1.1000
Key Highlights EUR/USD is holding gains above the 1.0920 support. A key bullish trend line is forming with support near 1.0965 on the 4-hour chart. GB...
April 24, 2023, 3:45 am
Apellis presents phase 3 functional analyses of syfovre™ (pegcetacoplan injection) for geographic atrophy
Showed visual function and quality-of-life benefits in patients with extrafoveal lesions Slowed the loss of retinal pigmented epithelial and photorece...
April 23, 2023, 10:05 pm
Why shares of keros therapeutics jumped this week
Keros is a pre-revenue biotech with two therapies in phase 2 trials. The company focuses on treatments ...
April 21, 2023, 1:55 pm
Eur/usd analysis ahead of pmi data signals $1.10 whipsaw
EUR/USD Technical View: The technical outlook for the EUR/USD is optimistic on the weekly chart, finding some comfort north of support at $1.0888. Tec...
April 21, 2023, 6:24 am
Legend (legn) stock up 20% on data leak from blood cancer study
Leaked data from Legend Biotech's (LEGN) phase III study of the blood cancer drug, Carvykti, shows a 74...
April 20, 2023, 12:11 pm
Biovie's degenerative dementia drug candidate to be presented at psychiatry conference
BioVie Inc (NASDAQ:BIVI) announced Thursday that a data abstract from its phase 2 open-label trial of i...
April 20, 2023, 10:24 am
Meta phased out covid-19 content labels after finding they did little to combat misinformation, oversight board says
Late last year, Facebook-parent Meta quietly phased out certain content labels on its platforms that for much of the pandemic had directed viewers to ...
April 20, 2023, 9:06 am
Why is dermata therapeutics (drma) stock up 22% today?
Dermata Therapeutics (NASDAQ: DRMA ) stock is on the rise Thursday following an update concerning its moderate-to-severe acne treatment. The big news ...
April 20, 2023, 8:49 am
Netflix in 'transitional phase' and may not see growth until 2024
KeyBanc Managing Director Justin Patterson and CFRA Research Director of Equity Research Ken Leon joined Yahoo Finance Live to discuss Netflix earning...
April 19, 2023, 5:00 pm
Revolo biotherapeutics announces positive topline data from phase 2a trial of ‘1104 in adults with active eosinophilic esophagitis
– Data shows achievement of primary endpoint of decreasing esophageal intraepithelial eosinophil count and positive impact on an array of histologic...
April 19, 2023, 12:00 pm
Greenbank capital announces successful first phase of fundraising
GreenBank Capital Inc (CSE:GBC) announced that it has closed the first tranche of its previously announced private placement offering for total gross ...
April 19, 2023, 10:29 am
Could this rare-disease drug candidate become a blockbuster?
AstraZeneca and Ionis recently shared promising phase 3 clinical trials for eplontersen. If approved, t...
April 19, 2023, 9:15 am
Revive therapeutics to review next steps for phase 3 bucillamine study in covid-19 patients
Revive Therapeutics Ltd (CSE:RVV, OTCQB:RVVTF) has said it will review the next steps for the phase 3 c...
April 19, 2023, 8:11 am
Time to take note of japan’s stock market again
Emerging markets and China’s risk premiums over Japan have been narrowed. Japan is considered a potential defensive play as its stock market valuati...
April 19, 2023, 7:14 am
Time to take note of japan’s stock market again
Emerging markets and China’s risk premiums over Japan have been narrowed. Japan is considered a potential defensive play as its stock market valuati...
April 19, 2023, 5:48 am
Allergy therapeutics peanut vaccine candidate negotiates its early clinical hurdle
Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF) has announced a significant milestone in its innovative peanut allergy treatment with the successful co...
April 19, 2023, 2:41 am
Immupharma partner gets fda meeting date
ImmuPharma PLC (AIM:IMM, OTC:IMMPF) has confirmed a Type-C meeting is scheduled with the US Food & Drug Administration for June 7. Scientists will di...
April 19, 2023, 2:28 am
Icymi - ecb's lane says bank will hike rate in may, +25 or +50bp is data dependent
European Central Bank Chief Economist Philip Lane was speaking at a Bloomberg(gated) New Economy Gateway Europe conference outside Dublin, in an inter...
April 18, 2023, 11:46 pm
3 reasons there is scope for the yen carry trade revival
This is via the folks at eFX. For bank trade ideas, check out eFX Plus. For a limited time, get a 7 day free trial, basic for $79 per month and premiu...
April 18, 2023, 9:43 pm